Comprehensive Real-Time News Feed for Novato, CA.
Results 1 - 5 of 5 for "u:biospace.com" in Novato, CA
DUBLIN, Ireland and NOVATO, Calif., Sept. 12, 2016 -- Horizon Pharma plc and Raptor Pharmaceutical Corp. today announced the companies have entered into a definitive agreement under which Horizon Pharma will acquire all of the issued and outstanding shares of Raptor Pharmaceutical Corp. common stock for $9.00 per share in cash, for an implied fully diluted equity value of approximately $800 million. Comment?
Cellular Dynamics International, Inc. , a FUJIFILM company , today announced that effective September 1, 2016 the company operations will be divided into two equally important business units. Emile Nuwaysir, PhD, President and Chief Operating Officer of CDI, will lead the Therapeutics Business Unit. Comment?
Improving On A Broccoli-Related Compound Yields A Possible Treatment For Macular Degeneration Buck Institute study also shows that palmitoleic acid protects the retina from environmental damage in mouse models of disease. July 6, 2016/Novato, CA: Buck researchers boosted the potency of a broccoli-related compound by ten times and identified it as a possible treatment for age-related macular degeneration , the leading cause of vision loss affecting more than 10 million older Americans. Comment?
April 19, 2016 By Alex Keown , BioSpace.com Breaking News Staff PARIS - To expand its manufacturing and commercial capabilities, French-based Sanofi will spend $339 million to expand its operations in Geel, Belgium, which is used to make the company's treatments for rare diseases. Sanofi said the investment will allow the company to expand existing production capabilities to support its pipeline of rare disease treatments, a market that the company believes it maintains a competitive position. Comment?
The stem cell disease model specialists recruit leading biologist, Prof Xianmin Zeng as Chief Scientific Officer Cambridge, UK, 12 January 2016: Axol Bioscience, a biotechnology company, specialising in the use of stem cell technology to manufacture disease relevant cell based assay systems to the drug discovery industry, today announced Prof Xianmin Zeng, PhD as Chief Scientific Officer . Prof Zeng is an accomplished biologist with over 15 years of academic expertise in the development of stem cell technologies and its applications. Comment?
- « Previous
- Next »
Copyright © 2016 Topix LLC